Trials / Unknown
UnknownNCT00247039
Garlic in Patients With Febrile Neutropenia
A Controlled Study to Determine The Clinical Efficacy Of Garlic Compounds In Patients With Chemotherapy Related Febrile Neutropenia
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Hadassah Medical Organization · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
To determine the clinical effects of garlic in preventing and treatment of patients with chemotherapy related febrile neutropenia.These patients have a very high incidence of infections which are not routinely covered by the standard empiric therapy. Adding a non- toxic and possibly effective therapy may reduce the risk for infections, synergize the empiric antibiotic treatment and may lessen the need for broader spectrum and more severe side effects.
Detailed description
Patients eligible are randomized to receive placebo or garlic capsules after chemotherapy course and until leukocyte recovery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Solgar Israel | Dietary Supplement: garlic natural compound one pill, 450 mg active garlic extract (Solgar, Israel), bid. |
| OTHER | Placebo capsules | placebo capsules |
Timeline
- Start date
- 2006-06-01
- Primary completion
- 2013-08-01
- Completion
- 2013-08-01
- First posted
- 2005-11-01
- Last updated
- 2013-07-08
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00247039. Inclusion in this directory is not an endorsement.